ARTICLE | Company News
Access Pharmaceuticals, AMAG Pharmaceuticals sales and marketing update
June 17, 2013 7:00 AM UTC
AMAG licensed exclusive, U.S. commercialization rights to MuGard mucoadhesive oral rinse from Access for an upfront payment of $3.3 million. Access is also eligible for a tiered, double-digit royalty...